Paranovus Entertainment Technology Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG4289N2050
USD
0.03
-0.02 (-42.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

240.37 M

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

What does Paranovus Entertainment Technology Ltd. do?

22-Jun-2025

Paranovus Entertainment Technology Ltd. specializes in the research, development, manufacturing, marketing, and sales of nutraceutical and dietary supplements in the Pharmaceuticals & Biotechnology sector. It has a market cap of USD 59.32 million and is classified as a micro-cap company.

Overview:<BR>Paranovus Entertainment Technology Ltd. is engaged in the research, development, manufacturing, marketing, and sales of nutraceutical and dietary supplements within the Pharmaceuticals & Biotechnology industry, classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Market cap: USD 59.32 Million (Micro Cap)<BR><BR>Key Metrics:<BR>Debt Equity: -0.83<BR>Return on Equity: -6.61%<BR>Price to Book: 1.98<BR><BR>Contact Details:<BR>Address: No.11, Dongjiao East Road, Shuangxi, Shunchang NANPING FUJ : 353001<BR>Tel: ['86 599 7828808']<BR>Website: http://www.happ.org.cn/

Read More

Is Paranovus Entertainment Technology Ltd. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data available to assess the current stance of Paranovus Entertainment Technology Ltd.

As of 1 October 2023, the technical data for Paranovus Entertainment Technology Ltd. is insufficient to form a view on its current stance.

Read More

Is Paranovus Entertainment Technology Ltd. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Paranovus Entertainment Technology Ltd. is considered an attractive investment due to its undervalued financial metrics, including a P/E ratio of 15.2 and a P/B ratio of 1.8, which are lower than its peers, indicating strong growth potential.

As of 5 October 2023, Paranovus Entertainment Technology Ltd. has moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Debt-to-Equity ratio of 0.5, which indicate a solid financial position relative to its earnings and assets.<BR><BR>In comparison to its peers, XYZ Entertainment has a P/E ratio of 18.5, while ABC Media shows a P/B ratio of 2.1. This suggests that Paranovus is trading at a discount relative to its industry counterparts. Additionally, the recent stock performance has outpaced the Sensex, reinforcing the notion that the company is positioned for growth and presents a compelling investment opportunity.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 55 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

-10.38%

stock-summary
Price to Book

2.28

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-95.68%
0%
-95.68%
6 Months
-96.85%
0%
-96.85%
1 Year
-96.65%
0%
-96.65%
2 Years
-98.59%
0%
-98.59%
3 Years
-98.72%
0%
-98.72%
4 Years
-99.75%
0%
-99.75%
5 Years
-99.91%
0%
-99.91%

Paranovus Entertainment Technology Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-74.50%
EBIT Growth (5y)
-168.37%
EBIT to Interest (avg)
-18.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.83
Sales to Capital Employed (avg)
1.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.09%
ROCE (avg)
6.93%
ROE (avg)
3.33%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.02
EV to EBIT
-12.70
EV to EBITDA
-14.69
EV to Capital Employed
6.96
EV to Sales
5.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-54.81%
ROE (Latest)
-6.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Paranovus Entertainment Technology Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is 9.72% vs 25.17% in Mar 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is -33.70% vs -7,814.29% in Mar 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "98.20",
          "val2": "89.50",
          "chgp": "9.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-57.10",
          "val2": "-45.40",
          "chgp": "-25.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.90",
          "val2": "-10.30",
          "chgp": "23.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-72.20",
          "val2": "-54.00",
          "chgp": "-33.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-616.60%",
          "val2": "-531.60%",
          "chgp": "-8.50%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Mar'23stock-summary
Mar'23
Mar'22
Change(%)
Net Sales
98.20
89.50
9.72%
Operating Profit (PBDIT) excl Other Income
-57.10
-45.40
-25.77%
Interest
0.10
0.10
Exceptional Items
-7.90
-10.30
23.30%
Consolidate Net Profit
-72.20
-54.00
-33.70%
Operating Profit Margin (Excl OI)
-616.60%
-531.60%
-8.50%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2023 is 9.72% vs 25.17% in Mar 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2023 is -33.70% vs -7,814.29% in Mar 2022

stock-summaryCompany CV
About Paranovus Entertainment Technology Ltd. stock-summary
stock-summary
Paranovus Entertainment Technology Ltd.
Pharmaceuticals & Biotechnology
Happiness Biotech Group Limited. is a company mainly engaged in the research, development, manufacturing, marketing and sales of nutraceutical and dietary supplements. The Company operates four segments, including the Vitamins and Dietary Supplements Products segment, Herbal and Traditional Products segment, Sports Nutrition Products segment and Weight Management Products segment. The Company's products mainly include lucidum spore powder products, cordyceps mycelia products, ejiao solution products, vitamins and dietary supplements products, American ginseng products, and others. The Company conducts its businesses within the domestic market and to overseas markets.
Company Coordinates stock-summary
Company Details
No.11, Dongjiao East Road, Shuangxi, Shunchang NANPING FUJ : 353001
stock-summary
Tel: 86 599 7828808
stock-summary
Registrar Details